Six-Month Outcomes of Combined Phacoemulsification and Kahook Dual Blade Excisional Goniotomy Surgery in Various Glaucoma Subtypes

不同类型青光眼患者接受超声乳化联合Kahook双刃切除性房角切开术的六个月疗效

阅读:1

Abstract

OBJECTIVES: To evaluate the efficacy and safety of the Kahook Dual Blade (KDB) excisional goniotomy procedure combined with phacoemulsification in patients with primary open-angle glaucoma (POAG), pseudoexfoliation glaucoma (PEXG), and primary angle-closure glaucoma (PACG). MATERIALS AND METHODS: This retrospective study included 25 eyes of 25 patients (13 males, 12 females) who underwent combined phacoemulsification and KDB excisional goniotomy for early- to moderate-stage glaucoma. Pre- and postoperative intraocular pressure (IOP), number of antiglaucoma medications, and best-corrected visual acuity (BCVA) were evaluated. Postoperative complications and surgical success rates were analyzed during a 6-month follow-up period. Surgical success was defined as a ≥20% reduction in IOP from baseline and IOP <18 mmHg, with or without medication. RESULTS: The patients' mean age was 67.0±11.9 years; 36% had POAG, 36% PEXG, and 28% PACG. The mean preoperative IOP was 22.7±6.0 mmHg, which significantly decreased to 12.8±2.2 mmHg at 6 months (p<0.05). The median number of medications decreased from 2 preoperatively to 0 postoperatively (p<0.05). There were no significant differences in 6-month IOP values (p=0.96) or IOP reduction rates (p=0.61) among glaucoma subtypes. BCVA improved from 0.5±0.4 to 0.1±0.1 logarithm of the minimum angle of resolution (p=0.001). The most common complications were transient hyphema (12%) and corneal edema (20%), all of which resolved with conservative/topical treatment. One patient required trabeculectomy at month 3, and 3 patients demonstrated less than 20% IOP reduction. The surgical success rate at month 6 was 84%. CONCLUSION: The KDB procedure combined with cataract surgery provided significant reductions in both IOP and the need for IOP-lowering medications at 6 months of follow-up in patients with early and moderate POAG, PACG, and PEXG, while maintaining a very low rate of complications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。